Ai X, MacPhedran S E, Hall A K
Department of Neurosciences, Case Western Reserve University, Cleveland, Ohio 44106-4975, USA.
J Neurosci. 1998 Nov 15;18(22):9294-302. doi: 10.1523/JNEUROSCI.18-22-09294.1998.
The neuropeptide calcitonin gene-related peptide (CGRP) is expressed by one-third of adult rat lumbar dorsal root ganglion (DRG) neurons, many of which mediate pain sensation or cause vasodilation. The factors that regulate the developmental expression of CGRP are poorly understood. Embryonic DRG neurons initially lack CGRP. When these neurons were stimulated in culture by serum or persistent 50 mM KCl application, the same percentage of CGRP-immunoreactive (CGRP-IR) neurons developed in vitro as was seen in the adult DRG in vivo. The addition of the L-type calcium channel blockers, 5 microM nifedipine or 10 microM verapamil, dramatically decreased the proportion of CGRP-IR neurons that developed, although the N-type calcium channel blocker, 2.5 microM omega-conotoxin, was less effective. By contrast, the sodium channel blocker 1 microM tetrodotoxin had no effect on CGRP expression after depolarization. Fura-2 ratiometric imaging demonstrated that mean intracellular free calcium levels increased from 70 to 135 nM with chronic depolarization, and the addition of nifedipine inhibited that increase. Only a subpopulation of neurons had elevated calcium concentrations during chronic depolarization, and they were correlated with CGRP expression. Key signal transduction pathways were tested pharmacologically for their role in CGRP expression after depolarization; the addition of the CaM kinase inhibitor KN-62 reduced the proportion of CGRP-IR neurons to basal levels. By contrast, protein kinase A and protein kinase C were not implicated in the depolarization-induced CGRP increases. These data suggest that depolarization and the subsequent Ca2+-based signal transduction mechanisms play important roles in the de novo expression of CGRP by specific embryonic DRG neurons.
神经肽降钙素基因相关肽(CGRP)由三分之一的成年大鼠腰段背根神经节(DRG)神经元表达,其中许多神经元介导痛觉或引起血管舒张。调节CGRP发育表达的因素尚不清楚。胚胎DRG神经元最初缺乏CGRP。当这些神经元在培养中受到血清刺激或持续应用50 mM氯化钾时,体外发育出的CGRP免疫反应性(CGRP-IR)神经元的比例与成年DRG体内所见相同。添加L型钙通道阻滞剂5 microM硝苯地平或10 microM维拉帕米,显著降低了发育出的CGRP-IR神经元的比例,尽管N型钙通道阻滞剂2.5 microMω-芋螺毒素的效果较差。相比之下,钠通道阻滞剂1 microM河豚毒素对去极化后CGRP的表达没有影响。Fura-2比率成像显示,慢性去极化使平均细胞内游离钙水平从70 nM增加到135 nM,添加硝苯地平可抑制这种增加。在慢性去极化过程中,只有一部分神经元的钙浓度升高,且它们与CGRP的表达相关。对关键信号转导通路在去极化后CGRP表达中的作用进行了药理学测试;添加CaM激酶抑制剂KN-62可将CGRP-IR神经元的比例降低至基础水平。相比之下,蛋白激酶A和蛋白激酶C与去极化诱导的CGRP增加无关。这些数据表明,去极化及随后基于Ca2+的信号转导机制在特定胚胎DRG神经元CGRP的从头表达中起重要作用。